Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Gainers

• Jounce Therapeutics, Inc. JNCE shares rose 36.8% to $1.45 in pre-market after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company for $1.80 per share subject to diligence and availability of at least $130m of cash and equivalents at closing.
• HUB Cyber Security (Israel) Ltd. HUBC rose 15.5% to $1.93 in pre-market trading after gaining more than 10% on Tuesday. HUB Security received $4 million from PIPE Investors at $10 per share.
• NeuroOne Medical Technologies Corporation NMTC rose 15.2% to $1.81 in pre-market trading after gaining around 5% on Tuesday.
• TC Biopharm (Holdings) Plc TCBP rose 14.1% to $3.49 in pre-market trading.
• Loyalty Ventures Inc. LYLT rose 13.2% to $0.1924 in pre-market trading after dipping 23% on Tuesday.
• Smartsheet Inc. SMAR rose 11.2% to $42.61 in pre-market trading after the company reported better-than-expected Q4 results and issued strong EPS guidance.
• Ambipar Emergency Response AMBI rose 10.5% to $13.54 in pre-market trading after jumping around 117% on Tuesday.
• Elevation Oncology, Inc. ELEV rose 9.8% to $1.57 in pre-market trading after jumping around 29% on Tuesday.
• Kingsoft Cloud Holdings Limited KC rose 8.6% to $4.43 in pre-market trading.

Losers

• Inpixon INPX fell 41.9% to $0.41 in pre-market. Inpixon completed distribution and business combination of CXApp Holding Corp. with KINS Technology Group Inc.
• Boxed, Inc. BOXD fell 38.8% to $0.26 in pre-market trading. Boxed is negotiating with lenders for bankruptcy sale, the Wall Street Journal reported.
• Celyad Oncology SA CYAD shares fell 25.1% to $0.7199 in pre-market trading. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
• Credit Suisse Group AG CS fell 22.3% to $1.95 in pre-market trading. Saudi Arabia's SNB said it cannot give more money to Credit Suisse because cannot go above 10% ownership due to regulatory issue.
• Intelligent Bio Solutions Inc. INBS fell 19.5% to $2.21 in pre-market trading. Intelligent Bio Solutions recently announced pricing of a $2.2 million public offering.
• Vacasa, Inc. VCSA fell 13.7% to $1.13 in pre-market trading after reporting Q4 results.
• Quoin Pharmaceuticals, Ltd. QNRX fell 12.1% to $0.4607 in pre-market trading. Quoin Pharmaceuticals recently posted a Q4 loss of $0.41 per share.
• Elys Game Technology, Corp. ELYS shares dropped 10.5% to $0.51 in pre-market trading after surging 33% on Tuesday.
• Merrimack Pharmaceuticals, Inc. MACK fell 10.3% to $10.50 in pre-market trading. Merrimack Pharmaceuticals recently posted a FY22 loss of $0.11 per share.
• Lannett Company, Inc. LCI shares fell 10.1% to $1.60 in pre-market trading after declining over 4% on Tuesday. Lannett recently posted upbeat Q2 results.

Now Read This: Adobe Likely To Report Higher Quarterly Earnings - Here's A Look At Recent Price Target Changes By The Most Accurate Analysts